Aspa Therapeutics: A Natural History Study of Patients With Canavan Disease

Aspa Therapeutics: A Natural History Study of Patients With Canavan Disease

(CANinform Study) [https://clinicaltrials.gov/study/NCT04126005]

CANinform is a natural history study of patients with Canavan disease that will help researchers better understand the disease and provide a foundation for Aspa’s gene therapy program. The study is open to individuals with a confirmed diagnosis of Canavan disease.